Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Japan | 2022

Procedure deferrals due to the COVID-19 pandemic severely impacted the Japanese GI endoscopy device market, and the elective nature of many postponed procedures will hinder the pace of recovery to some extent. Nonetheless, following short-term disruption due to the global pandemic, the Japanese GI endoscopy device market will grow modestly due to the high incidence of gastric cancer and broad coverage for CRC screening in the country; however, reimbursement cuts and demographic patterns will limit growth opportunities.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for GI endoscopy devices in Japan across an 11-year period.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Urological Devices – Market Insights – Japan
The Japanese urological device market will continue to expand through 2034, driven by the rising prevalence of risk factors for urological disorders, such as the growing burden of metabolic…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Japan
The Japanese EP mapping and ablation device market will experience moderate growth through 2034, supported by rising cardiac arrhythmia prevalence, broader treatment accessibility, and ongoing…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…